Skip to main content
MedPathMedPath Home
Clinical Trials/2025-522147-18-00
2025-522147-18-00
Recruiting
Phase 1

A clinical trial of MK-7228 in adults (MK-7228-002)

Merck Sharp & Dohme LLC1 site in 1 country40 target enrollmentStarted: March 31, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Status
Recruiting
Enrollment
40
Locations
1
OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Kelly Duncan

Scientific

Merck Sharp & Dohme LLC

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
A clinical study of MK-2828 in healthy people (MK-2828-001)
2024-513377-51-00Merck Sharp & Dohme LLC16
Recruiting
Phase 1
A clinical trial of MK-6916 in healthy participants (MK-6916-010)
2025-524570-41-00Merck Sharp & Dohme LLC54
Recruiting
Phase 1
A clinical study of MK-1289 in healthy adult men (MK-1289-001)
2025-521395-63-00Merck Sharp & Dohme LLC28
Recruiting
Phase 1
A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
NCT07348237Merck Sharp & Dohme LLC24
Recruiting
Phase 2
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
NCT07463183Merck Sharp & Dohme LLC100